About Maryam Shansab
Form D filings for Intolerant Antibodies in 2024 list Maryam Shansab as executive officer and director.
Maryam Shansab first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Maryam Shansab in the role, so the role may have started earlier or lasted longer.